AstraZeneca (LON:AZN) Share Price Passes Above 200 Day Moving Average - Time to Sell?

Key Points

• AstraZeneca's share price has surpassed its 200-day moving average, reaching a high of £127.50 during trading, with the last recorded price at £124.54.
• Analysts are mostly optimistic, with the consensus rating being a "Moderate Buy" and a target price of £131.75, supported by recommendations from multiple firms.
• Insider Aradhana Sarin sold 9,563 shares at an average price of £115.12, indicating possible insider confidence or market adjustments.

AstraZeneca PLC (LON:AZN - Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of £108.98 ($146.50) and traded as high as £127.50 ($171.39). AstraZeneca shares last traded at £124.54 ($167.41), with a volume of 2,725,337 shares changing hands.

Wall Street Analyst Weigh In

A number of research firms recently commented on AZN. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and issued a £110 price objective on shares of AstraZeneca in a report on Wednesday, July 30th. Berenberg Bank reaffirmed a "buy" rating and set a £142 price target on shares of AstraZeneca in a report on Monday, September 1st. Finally, Shore Capital reissued a "buy" rating and set a £135 price target on shares of AstraZeneca in a report on Tuesday, July 29th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of £131.75.

AstraZeneca Trading Up 0.1%

The firm has a 50-day moving average of £115.48 and a 200 day moving average of £108.98. The company has a current ratio of 0.93, a quick ratio of 0.59 and a debt-to-equity ratio of 73.83. The company has a market cap of £193.07 billion, a P/E ratio of 2,345.39, a price-to-earnings-growth ratio of 0.86 and a beta of 0.17.

Insider Transactions at AstraZeneca

In related news, insider Aradhana Sarin sold 9,563 shares of AstraZeneca stock in a transaction on Thursday, August 14th. The stock was sold at an average price of £115.12, for a total transaction of £1,100,892.56. Corporate insiders own 0.14% of the company's stock.

AstraZeneca Company Profile

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.